Open label, single arm safety prospective cohort study o

Project: Research project

Project Details

Description

Open label, single arm safety prospective cohort study of dabigatran etexilate for secondary prevention of venous thromboembolism in children from 0 to less than 18 years
StatusFinished
Effective start/end date4/1/163/31/20

Funding

  • Boehringer-Ingelheim Pharmaceuticals

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.